Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY24 results · Apr–Jun 2023
Wockhardt reported revenue from operations of ₹644.00 crore (up 8.2% from Q1 FY23) and net loss of ₹136.00 crore for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 644.00 | 595.00 | +8.2% | 678.00 | −5.0% |
| Other income | 14.00 | 57.00 | −75.4% | 32.00 | −56.2% |
| Total income | 658.00 | 652.00 | +0.9% | 710.00 | −7.3% |
| Profit before tax | (118.00) | (96.00) | Loss widened | (193.00) | Loss narrowed |
| Net profit for the period | (136.00) | (75.00) | Loss widened | (237.00) | Loss narrowed |
| Attributable to shareholders of the company | (134.00) | (67.00) | Loss widened | (208.00) | Loss narrowed |
| EPS, basic (₹) | (9.28) | (4.64) | Loss widened | (14.37) | Loss narrowed |
| Net margin (%) | -21.1 | -12.6 | -35.0 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 251.00 | 241.00 | +4.1% | 291.00 | −13.7% |
| Other income | 6.00 | 49.00 | −87.8% | 29.00 | −79.3% |
| Total income | 257.00 | 290.00 | −11.4% | 320.00 | −19.7% |
| Profit before tax | (115.00) | (54.00) | Loss widened | (289.00) | Loss narrowed |
| Net profit for the period | (115.00) | (37.00) | Loss widened | (299.00) | Loss narrowed |
| EPS, basic (₹) | (8.01) | (2.62) | Loss widened | (20.80) | Loss narrowed |
| Net margin (%) | -45.8 | -15.4 | -102.7 |
Consolidated
- Filed with BSE
- 14 Aug 2023, 17:56 IST
- Board meeting
- 14 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Aug 2023, 17:56 IST
- Board meeting
- 14 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE